Latest Licensing Agreements News

Page 2 of 23
TALi Digital (ASX:TD1) is raising up to $3.3 million through a Security Purchase Plan and Placement to fund its acquisition of Datasphere Analytics and advance its AI-driven education platform.
Sophie Babbage
Sophie Babbage
1 Sept 2026
Audeara Limited delivered record FY26 revenue of $4.45 million, driven by a 45% surge in Australian wholesale sales and progress in AI audio licensing with OPTEK Microelectronics. The company narrowed its loss and advanced Auracast deployments across retirement villages and education sectors.
Victor Sage
Victor Sage
31 Aug 2026
Weebit Nano surged to record revenue of $15.3 million in FY26, fueled by key licensing deals and product tape-outs, while investing heavily in R&D and AI initiatives. Despite a $54.9 million loss, a $102 million capital raise leaves the company well-positioned for growth.
Sophie Babbage
Sophie Babbage
28 Aug 2026
Argent BioPharma has secured a key FDA regulatory milestone with the establishment of an Investigational New Animal Drug (INAD) file for its CannEpil veterinary program, targeting cancer-related pain in companion animals.
Victor Sage
Victor Sage
26 Aug 2026
Ainsworth Game Technology’s first half 2026 results reveal a sharp revenue drop driven by North American and Latin American market pressures, offset partially by Asia Pacific growth and a key patent licensing deal.
Victor Sage
Victor Sage
26 Aug 2026
Acrux Limited reported a 46% revenue increase to $6.6 million in FY26, driven by US generic product royalties and licensing milestones, while narrowing its net loss by 90%. The company is pivoting towards developing a female testosterone therapy with encouraging Phase II data and active regulatory engagement.
Ada Torres
Ada Torres
26 Aug 2026
Nine Entertainment Co. Holdings Limited posted a $511 million statutory net profit for FY26, driven by significant portfolio restructuring and growth in digital and outdoor advertising, while advancing AI licensing partnerships.
Victor Sage
Victor Sage
26 Aug 2026
NeuroScientific Biopharmaceuticals posted a $4.69 million loss for FY2026, driven by R&D ramp-up and clinical progress with its StemSmart™ platform, while halting independent development of its glaucoma drug EmtinB to pursue licensing deals.
Ada Torres
Ada Torres
25 Aug 2026
Nanoveu’s half-year report reveals a sharp drop in revenue and a widening net loss, offset by key technological milestones including a 16nm AI chip tape-out, drone efficiency gains, and a strategic robotics acquisition.
Sophie Babbage
Sophie Babbage
24 Aug 2026
TALi Digital is acquiring Datasphere Analytics to access cutting-edge memristive in-memory computing technology, aiming to enhance its AI-driven education platform. The company is concurrently raising $3.3 million to fund this strategic move and ongoing operations.
Sophie Babbage
Sophie Babbage
24 Aug 2026
Dimerix has received a US$10 million upfront payment from Everest Medicines under a regional licensing deal for DMX-200 targeting FSGS in Greater China, South Korea and Southeast Asia. This deal marks Dimerix’s fifth commercial partnership for DMX-200, collectively worth up to A$1.9 billion in milestones and royalties.
Ada Torres
Ada Torres
20 Aug 2026
Yowie Group's revenue declined in the first half of 2026 as it navigated supply chain shifts and cautious retail demand, but the company secured a significant Australian licensing deal and ended costly legacy litigation.
Victor Sage
Victor Sage
19 Aug 2026

Browse the archive

Full archive